ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years
Jolanda Spadavecchia
Matched on ORCID iD 0000-0001-6697-1174; OpenAlex author ID A5044603023. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: 2 papers
Papers 6
- Retraction Note: Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells. First author DOI 10.1007/s11051-025-06264-8↗
- Doxorubicin-NFL-TBS.40-63 peptide Gold Complex Nanovector (DOX IN-NFL@AuNPs): Efficacy Evaluation in a mouse transplantation tumor model induced by PANC-1/ADR … Last author DOI 10.7150/ntno.109280↗
- NFL-TBS.40-63 Peptide Gold Complex Nanovector: A Novel Therapeutic Approach to Increase Anticancer Activity by Breakdown of Microtubules in Pancreatic Adenocar… Last author DOI 10.1021/acsptsci.2c00159↗
- Erratum: Targeted Polyethylene Glycol Gold Nanoparticles for the Treatment of Pancreatic Cancer: From Synthesis to Proof-of-Concept in vitro Studies [Corrigend… Co-author DOI 10.2147/ijn.s384663↗
- Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies. Co-author DOI 10.2147/ijn.s97476↗
- Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells. First author DOI 10.1007/s11051-013-2111-6↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qiqian Liu · 2 shared papers, 2022–2025 · strength 0.48
- Paper Doxorubicin-NFL-TBS.40-63 peptide Gold Complex Nanovector (DOX IN-NFL@AuNPs): Efficacy Evaluation in a mouse transplant… DOI 10.7150/ntno.109280↗
- Paper NFL-TBS.40-63 Peptide Gold Complex Nanovector: A Novel Therapeutic Approach to Increase Anticancer Activity by Breakdow… DOI 10.1021/acsptsci.2c00159↗
- Xiaowu Li · 2 shared papers, 2022–2025 · strength 0.48
- Paper Doxorubicin-NFL-TBS.40-63 peptide Gold Complex Nanovector (DOX IN-NFL@AuNPs): Efficacy Evaluation in a mouse transplant… DOI 10.7150/ntno.109280↗
- Paper NFL-TBS.40-63 Peptide Gold Complex Nanovector: A Novel Therapeutic Approach to Increase Anticancer Activity by Breakdow… DOI 10.1021/acsptsci.2c00159↗
- Angelica Sette · 2 shared papers, 2013–2025 · strength 0.32
- Paper Retraction Note: Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic … DOI 10.1007/s11051-025-06264-8↗
- Paper Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarci… DOI 10.1007/s11051-013-2111-6↗
- Annarosa Arcangeli · 2 shared papers, 2013–2025 · strength 0.32
- Paper Retraction Note: Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic … DOI 10.1007/s11051-025-06264-8↗
- Paper Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarci… DOI 10.1007/s11051-013-2111-6↗
- Hui Liu · 1 shared paper, 2025 · strength 0.30
- Adriele Prina‐Mello · 2 shared papers, 2016–2022 · strength 0.23
- Paper Erratum: Targeted Polyethylene Glycol Gold Nanoparticles for the Treatment of Pancreatic Cancer: From Synthesis to Proo… DOI 10.2147/ijn.s384663↗
- Paper Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-conc… DOI 10.2147/ijn.s97476↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.